| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 435797
[patent_doc_number] => 07262052
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-08-28
[patent_title] => 'α-2/δ gene'
[patent_app_type] => utility
[patent_app_number] => 09/787657
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16536
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262052.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787657
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787657 | α-2/δ gene | Oct 6, 1999 | Issued |
Array
(
[id] => 1515449
[patent_doc_number] => 06420532
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Method of obtaining compositions comprising Y2 specific compounds'
[patent_app_type] => B1
[patent_app_number] => 09/407367
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 48
[patent_no_of_words] => 34298
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420532.pdf
[firstpage_image] =>[orig_patent_app_number] => 09407367
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/407367 | Method of obtaining compositions comprising Y2 specific compounds | Sep 28, 1999 | Issued |
Array
(
[id] => 1208974
[patent_doc_number] => 06713265
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)'
[patent_app_type] => B1
[patent_app_number] => 09/194895
[patent_app_country] => US
[patent_app_date] => 1999-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 47
[patent_no_of_words] => 51901
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713265.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194895
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194895 | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) | Sep 26, 1999 | Issued |
Array
(
[id] => 386660
[patent_doc_number] => 07304029
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-12-04
[patent_title] => 'Neuroprotective effect of growth hormone'
[patent_app_type] => utility
[patent_app_number] => 09/786982
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8049
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/304/07304029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09786982
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/786982 | Neuroprotective effect of growth hormone | Sep 2, 1999 | Issued |
| 09/378567 | USES OF TGFA AND RELATED POLYPEPTIDES | Aug 18, 1999 | Abandoned |
Array
(
[id] => 1516991
[patent_doc_number] => 06500638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-31
[patent_title] => 'Prostatic growth factor'
[patent_app_type] => B2
[patent_app_number] => 09/361741
[patent_app_country] => US
[patent_app_date] => 1999-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12517
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09361741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/361741 | Prostatic growth factor | Jul 27, 1999 | Issued |
Array
(
[id] => 1457664
[patent_doc_number] => 06391285
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Antimicrobial polypeptide and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/361900
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5519
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391285.pdf
[firstpage_image] =>[orig_patent_app_number] => 09361900
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/361900 | Antimicrobial polypeptide and methods of use | Jul 26, 1999 | Issued |
Array
(
[id] => 6656570
[patent_doc_number] => 20030009777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'GALANIN'
[patent_app_type] => new
[patent_app_number] => 09/230463
[patent_app_country] => US
[patent_app_date] => 1999-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3070
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20030009777.pdf
[firstpage_image] =>[orig_patent_app_number] => 09230463
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/230463 | GALANIN | Jul 25, 1999 | Abandoned |
| 09/329531 | DNA ENCODING CYTOKINE DESIGNATED LERK-5 | Jun 9, 1999 | Abandoned |
| 09/327745 | METHODS FOR ALTERING CIRCADIAN RHYTHMS AND METHODS FOR PHOSPHORYLATING HUMAN CLOCK PROTEIN, PERIOD 1, BY HUMAN CASEIN KINASE IE | Jun 7, 1999 | Abandoned |
Array
(
[id] => 1354702
[patent_doc_number] => 06572866
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-03
[patent_title] => 'Nerve growth factor as a vaccine adjuvant'
[patent_app_type] => B1
[patent_app_number] => 09/269883
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10703
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/572/06572866.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269883
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269883 | Nerve growth factor as a vaccine adjuvant | May 31, 1999 | Issued |
Array
(
[id] => 1545709
[patent_doc_number] => 06444643
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity'
[patent_app_type] => B1
[patent_app_number] => 09/321762
[patent_app_country] => US
[patent_app_date] => 1999-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5280
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444643.pdf
[firstpage_image] =>[orig_patent_app_number] => 09321762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/321762 | Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity | May 27, 1999 | Issued |
Array
(
[id] => 1542232
[patent_doc_number] => 06372487
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein'
[patent_app_type] => B1
[patent_app_number] => 09/315720
[patent_app_country] => US
[patent_app_date] => 1999-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11083
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372487.pdf
[firstpage_image] =>[orig_patent_app_number] => 09315720
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/315720 | Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein | May 19, 1999 | Issued |
Array
(
[id] => 975314
[patent_doc_number] => 06933122
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-23
[patent_title] => 'A-form of cytoplasmic domain of nARIA (CRD-neuregulin) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/312596
[patent_app_country] => US
[patent_app_date] => 1999-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 46
[patent_no_of_words] => 24106
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933122.pdf
[firstpage_image] =>[orig_patent_app_number] => 09312596
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/312596 | A-form of cytoplasmic domain of nARIA (CRD-neuregulin) and uses thereof | May 13, 1999 | Issued |
Array
(
[id] => 4302323
[patent_doc_number] => 06326170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Prokaryotic polynucleotides, polypeptides and their uses'
[patent_app_type] => 1
[patent_app_number] => 9/308003
[patent_app_country] => US
[patent_app_date] => 1999-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33408
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326170.pdf
[firstpage_image] =>[orig_patent_app_number] => 308003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/308003 | Prokaryotic polynucleotides, polypeptides and their uses | May 9, 1999 | Issued |
Array
(
[id] => 4405935
[patent_doc_number] => 06238873
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof'
[patent_app_type] => 1
[patent_app_number] => 9/303524
[patent_app_country] => US
[patent_app_date] => 1999-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11456
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/238/06238873.pdf
[firstpage_image] =>[orig_patent_app_number] => 303524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/303524 | Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof | Apr 29, 1999 | Issued |
Array
(
[id] => 5987304
[patent_doc_number] => 20020099008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'METHOD FOR STIMULATING HEMATOPOIESIS USING TGF-ALPHA'
[patent_app_type] => new
[patent_app_number] => 09/299473
[patent_app_country] => US
[patent_app_date] => 1999-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8467
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099008.pdf
[firstpage_image] =>[orig_patent_app_number] => 09299473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/299473 | METHOD FOR STIMULATING HEMATOPOIESIS USING TGF-ALPHA | Apr 25, 1999 | Abandoned |
| 09/284749 | METHOD FOR THE IDENTIFICATION OF COMPOUNDS WITH ANXIOLYTIC POTENTIAL | Apr 19, 1999 | Abandoned |
Array
(
[id] => 6618258
[patent_doc_number] => 20020086009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'ANTI-PHOSPHORYLATED TAU PROTEIN ANTIBODIES AND METHODS FOR DETECTING ALZHEIMER`S DISEASE WITH THE USE OF THE SAME'
[patent_app_type] => new
[patent_app_number] => 09/142613
[patent_app_country] => US
[patent_app_date] => 1999-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9111
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086009.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142613
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142613 | ANTI-PHOSPHORYLATED TAU PROTEIN ANTIBODIES AND METHODS FOR DETECTING ALZHEIMER`S DISEASE WITH THE USE OF THE SAME | Apr 18, 1999 | Abandoned |
Array
(
[id] => 4222016
[patent_doc_number] => 06040428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Porcine E-selectin'
[patent_app_type] => 1
[patent_app_number] => 9/276197
[patent_app_country] => US
[patent_app_date] => 1999-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 17441
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040428.pdf
[firstpage_image] =>[orig_patent_app_number] => 276197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/276197 | Porcine E-selectin | Mar 24, 1999 | Issued |